Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MD.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
MD.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
MD.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
MD.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
MD.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MD.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LZ.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LZ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LZ.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LZ.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LZ.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LZ.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LZ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LZ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.3.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.3.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.3.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.3.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KW.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KW.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KW.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KW.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KW.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KW.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KW.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KU.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KU.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KU.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KU.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KU.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KU.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
JN.1.4.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
JN.1.4.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
JN.1.4.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
JN.1.4.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
JN.1.4.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
JN.1.4.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
JN.1.4.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used